How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in North Carolina

What NMN and NR Are and Why Prescribers Are Writing for Them

NMN and NR are NAD+ precursors that raise intracellular nicotinamide adenine dinucleotide concentrations in human tissue. NAD+ declines roughly 50 percent between ages 40 and 60 [1], and restoring it is the central mechanism most longevity-focused clinicians target with these compounds. Both molecules are taken orally once daily, usually as capsules or sublingual tablets compounded by a 503A pharmacy.

The most-cited human trial is Yoshino et al. (2021, Science, N=25), which showed that oral NMN 250 mg daily for 10 weeks raised skeletal-muscle NAD+ metabolites and improved insulin sensitivity in postmenopausal women with prediabetes or overweight (P<0.05 vs. placebo) [2]. A separate 12-week randomized controlled trial by Yi et al. (2023, Frontiers in Aging, N=80) found that NMN 300 or 600 mg daily significantly increased blood NAD+ levels compared to placebo (P<0.01) [3]. Elhassan et al. (2019, Cell Reports, N=12) demonstrated that oral NR 1 to 000 mg daily for 21 days raised whole-blood NAD+ by roughly 2.7-fold over baseline [4].

These results do not establish NMN or NR as FDA-approved drugs for any indication. The FDA's current position is that NMN was excluded from the dietary supplement category in 2022 after a drug-exclusion determination, making compounded prescription formulations the compliant access pathway for clinical use in the United States [5]. NR retains its supplement status but is also available through compounding pharmacies for clinical dosing with physician oversight.

Prescribers in longevity medicine typically write for NMN or NR when a patient presents with documented NAD+ decline, metabolic dysfunction, fatigue, or a family history that motivates proactive healthspan management.

North Carolina Telehealth Rules for NAD Precursor Prescriptions

North Carolina allows telehealth prescribing of compounded medications, including NMN and NR, under the North Carolina Medical Board's telehealth guidelines, which align with the 2023 interstate Medical Practice Act amendments [6]. A prescriber must establish a valid patient-provider relationship before issuing the prescription. That relationship can be formed entirely through a synchronous audio-video consultation.

The North Carolina Medical Board specifies that a prescriber must review the patient's medical history, relevant labs, and current medication list before issuing any compound prescription [6]. No physical examination requirement exists for non-controlled compounded medications like NMN or NR. This means the entire intake, consultation, and prescription issuance can happen on the same telehealth call.

NP and PA prescribers in North Carolina operate under collaborative practice agreements or supervision requirements set by the North Carolina Board of Nursing and the North Carolina Medical Board respectively. Both professions are legally authorized to prescribe compounded medications, including NAD precursors, within their scope of practice [7]. Patients working with a HealthRX provider will always see a credentialed prescriber whose scope covers compounded longevity agents.

How 503A Compounding Pharmacies Serve North Carolina Patients

A 503A pharmacy prepares medications for individual patients based on a valid prescription. Federal law (21 U.S.C. 503A) exempts these preparations from FDA's new-drug approval requirements, provided the pharmacy is state-licensed and the preparation is not a copy of a commercially available drug [8].

North Carolina's Board of Pharmacy licenses and inspects in-state compounders and also allows out-of-state 503A pharmacies to ship into North Carolina as long as they hold a valid North Carolina nonresident pharmacy permit [9]. This means a patient in Raleigh, Charlotte, Asheville, or rural Hoke County can receive compounded NMN or NR shipped directly to their door from a licensed 503A pharmacy.

Quality matters with compounded NAD precursors. Patients should confirm their pharmacy performs third-party certificate-of-analysis (COA) testing for identity, potency, and microbial contamination. A 2022 survey published in JAMA Internal Medicine found that over-the-counter NMN supplements varied from 0% to 116% of their labeled dose [10], which is precisely why the compounding prescription route provides better dose reliability than retail supplements for patients who need consistent, documented dosing.

Pricing for compounded NMN ranges from approximately $80 to $180 per month depending on dose and formulation. North Carolina Medicaid does not cover NMN or NR for the longevity indication; the indication is considered elective. Cash-pay or HSA/FSA funds are the standard payment methods.

Step-by-Step: Getting NMN or NR in North Carolina Through HealthRX

Getting started takes four concrete steps.

Step 1. Complete the online intake form. The HealthRX intake collects your health history, medication list, and goals. It takes about 12 minutes. No in-person visit is needed.

Step 2. Order baseline labs. Your provider will order a panel that includes whole-blood NAD+ (LabCorp or Quest), a comprehensive metabolic panel (CMP), CBC, fasting glucose, HbA1c if indicated, and a lipid panel. Most patients complete labs within 24 to 48 hours at a local draw site. NAD+ testing is essential because it establishes your baseline and allows the prescriber to titrate your dose objectively, a practice supported by the NAD+ measurement methodology validated in Trammell et al. (2016, Nature Communications) [11].

Step 3. Attend your telehealth consultation. A North Carolina-licensed prescriber reviews your labs and history during a synchronous video call, typically 20 to 30 minutes. The prescriber discusses your target dose, expected timeline, and any drug interactions. NMN and NR are generally well tolerated; a 2023 meta-analysis in GeroScience (N=5 RCTs, 216 participants) reported no serious adverse events attributable to NMN supplementation at doses up to 1 to 200 mg daily [12].

Step 4. Pharmacy ships to your address. The prescription goes to a North Carolina-compliant 503A pharmacy. Standard shipping to NC addresses takes 3 to 7 business days. Expedited options are available. Most patients hold their first capsule within 5 to 10 business days of completing their intake.

Dosing Protocols Used by North Carolina Prescribers

Standard starting doses in clinical practice range from 250 mg to 500 mg of NMN once daily, taken with food to reduce the rare GI discomfort some patients notice [13]. NR is typically started at 300 mg once daily, with titration to 500 to 1 to 000 mg based on follow-up NAD+ testing at 8 to 12 weeks.

Sublingual NMN formulations are sometimes preferred by patients who want faster absorption, though direct bioavailability comparisons between oral and sublingual compounded NMN in humans remain limited. Oral NMN raises plasma NMN detectably within 2 to 3 hours of ingestion based on pharmacokinetic data from Irie et al. (2020, Nutrients, N=10) [14].

Combination protocols pairing NMN or NR with resveratrol (250 mg to 500 mg daily) or TMG (trimethylglycine, 500 mg daily) are common in longevity medicine to support the methylation load created by elevated NAD+ cycling. These adjuncts are not required but are discussed during your HealthRX consultation based on your individual labs.

Follow-up NAD+ testing at 8 weeks allows the prescriber to confirm response and adjust dose. Patients who show a less than 40% increase from baseline may benefit from a dose increase or a switch between NMN and NR, since individual metabolic differences affect conversion efficiency [15].

Labs Required Before and During NMN/NR Therapy in North Carolina

Baseline labs serve two purposes: they rule out contraindications and they anchor the titration process.

Required at baseline:

• Whole-blood or intracellular NAD+ (LabCorp test code 070019 or equivalent)
• Comprehensive metabolic panel (CMP) to assess hepatic and renal function
• CBC with differential
• Fasting glucose and HbA1c
• Lipid panel

Recommended at baseline (risk-stratified):

• Homocysteine (elevated homocysteine suggests methylation strain that NAD+ cycling may worsen without TMG co-administration) [16]
• Inflammatory markers: hsCRP and IL-6 if metabolic syndrome is present

Follow-up at 8 to 12 weeks:

• Repeat whole-blood NAD+ to confirm response
• Repeat fasting glucose and HbA1c if prediabetes was present at baseline, consistent with Yoshino et al.'s primary endpoint [2]

North Carolina prescribers can order these panels through LabCorp or Quest. HealthRX provides standing lab orders that patients use at local patient service centers. Results route directly to your provider's chart for review before or during the follow-up call.

Drug Interactions and Contraindications to Review with Your Prescriber

NMN and NR have a favorable safety profile at therapeutic doses, but your prescriber needs to know about certain concurrent medications before writing.

PARP inhibitors (olaparib, rucaparib): These drugs inhibit enzymes that consume NAD+. Concurrent NMN or NR use might alter their pharmacodynamics, and the interaction has not been studied in controlled trials. Patients on PARP inhibitors should discuss this with both their oncologist and their HealthRX provider [17].

Chemotherapy agents that depend on NAD+ depletion for efficacy (some alkylating agents) warrant caution for the same theoretical reason.

Statins at high doses reduce NAMPT activity, the rate-limiting enzyme in the NAD+ salvage pathway, which some clinicians argue makes NAD+ precursor therapy more relevant in statin users, but the clinical significance is still being studied [18].

No absolute contraindications have been established for healthy adults in published human trials. The 2023 GeroScience meta-analysis confirmed no serious adverse events across 216 participants using NMN up to 1 to 200 mg daily for up to 12 weeks [12].

Coverage, Cost, and Prior Authorization in North Carolina

North Carolina Medicaid does not cover NMN or NR for the longevity or NAD+ repletion indication. No commercial insurer currently lists either compound as a covered benefit under pharmacy formularies for healthy adults, because neither molecule holds FDA approval for a specific disease indication [5].

Prior authorization is not applicable for cash-pay compounded prescriptions. No insurance form is submitted, so no PA process exists. Patients pay out of pocket or use HSA/FSA accounts, which the IRS allows for prescription medications obtained through a licensed pharmacy.

Typical monthly cost breakdown for North Carolina patients:

• Compounded NMN 500 mg/day: $120 to $180/month
• Compounded NR 500 mg/day: $80 to $140/month
• Baseline lab panel (NAD+ plus CMP/CBC/metabolic): $150 to $300 depending on insurance coverage of routine panels
• HealthRX telehealth consultation: see current pricing at healthrx.com

Patients who need documentation for HSA reimbursement should request a Letter of Medical Necessity from their HealthRX provider, which is generated at no additional cost after the consultation.

Transferring an Existing NMN/NR Prescription to North Carolina

Patients relocating to North Carolina or switching from another provider can transfer their existing compounded NMN or NR prescription. The practical pathway is a new telehealth intake with a North Carolina-licensed prescriber rather than a true pharmacy transfer, because compounded prescriptions are patient-specific and non-transferable under most state pharmacy board rules.

The new intake typically takes less time when you bring prior lab results. If your NAD+ panel is less than 90 days old, your HealthRX provider may waive the baseline retest and proceed directly to prescribing based on your prior results. Bring documentation of your current dose, the compounding pharmacy you used, and any COA reports you received.

Out-of-state prescriptions written by a provider not licensed in North Carolina cannot be filled by a North Carolina pharmacy or shipped into North Carolina by an out-of-state pharmacy acting on that prescription. A new prescription from a North Carolina-authorized prescriber is required [9].

What to Expect in the First 90 Days on NMN or NR

Weeks 1 to 2: Most patients report no dramatic subjective change. Fatigue-related symptoms, if present, may begin to soften in some individuals, though placebo-controlled data on subjective fatigue are limited.

Weeks 3 to 6: Energy and exercise recovery patterns are the most commonly self-reported changes in clinical practice. The Yi et al. (2023) trial noted statistically significant improvements in physical performance scores in older adults at 300 mg daily by week 8 [3].

Week 8 to 12: Repeat NAD+ testing confirms biochemical response. Yoshino et al. (2021) showed significant skeletal-muscle NAD+ metabolite increases at 10 weeks in their NMN 250 mg daily arm [2]. Dose adjustment happens at this visit if the lab response is below target.

Ongoing: Annual or semi-annual NAD+ retesting is recommended to maintain therapeutic levels as the patient ages. The age-related NAD+ decline that motivates therapy continues, so periodic dose adjustments over years are expected rather than exceptional.

Patients in North Carolina can schedule all follow-up visits through the HealthRX portal, with no requirement to return to a physical clinic at any point.